North America Lung Transplant Therapeutics Market, By Product (Immunosuppressant Drugs, Organ Preservation Products, Tissue Product and Others), Indication (Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, Septic Lung Disease, Pulmonary Hypertension, Cystic Fibrosis, Interstitial Pulmonary Fibrosis, Emphysema, Sarcoidosis, Primary Pulmonary Arterial Hypertension and Other), Type (Cadaveric Lung Transplantation, Living Lung Transplantation), Technique (Single - Lung Transplantation, Bilateral - Lung Transplantation, Heart - Lung Transplantation, Double - Lung Transplantation), Patient Demographics (Geriatric, Adult, Paediatric), End User (Hospitals, Transplant Centres, Specialty Centres and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2029